ArticleScientific reports2019

Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion.

Jeong Uk Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.